Cadila Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?
CADILA PHARMS LTD has thirty approved drugs.
Drugs and US Patents for Cadila Pharms Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadila Pharms Ltd | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206173-002 | May 5, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Cadila Pharms Ltd | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET;ORAL | 208606-002 | Jan 16, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Cadila Pharms Ltd | PREGABALIN | pregabalin | CAPSULE;ORAL | 206452-004 | Jul 12, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.